New drug combo tested for Tough-to-Treat leukemia
NCT ID NCT07178912
Summary
This study is testing if a new combination of two drugs, given as an injection and a pill, can help control a specific type of aggressive blood cancer called Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL). It will involve about 60 adults, either newly diagnosed or whose cancer has returned. The main goals are to see if the treatment can make the cancer undetectable by very sensitive tests and to monitor side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHASE II CLINICAL TRIAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.